Skip to main content
OpenTrials

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies
Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Recruiting

Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

NCT06607419

Conditions
B-Cell Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Fujian Children's Hospital Fuzhou, Fujian, China
  • Shanghai Children's Medical center Shanghai, Shanghai Municipality, China
  • Ningbo Women and Children's Hospital Ningbo, Zhejiang, China
View Trial Details
Recruiting

Effect of HPV Integration on Prognosis of Young Women With CIN2 in China

NCT05282095

Conditions
Cervical Intraepithelial Neoplasia, Communicable Diseases, DNA Virus Infections, +24 more
Locations
  • Fujian Maternity and Child Health Hospital Fuzhou, Fujian, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • Longyan First Hospital Longyan, Fujian, China
View all 20 locations
View Trial Details
Recruiting

Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

NCT06450067

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

NCT04989491

Conditions
DNA Virus Infections, Epstein-Barr Virus Infections, Herpesviridae Infections, +3 more
Locations
  • Les Hôpitaux Universitaires de Strasbourg Strasbourg, France
View Trial Details

Related conditions